Results 11 to 20 of about 20,468 (186)

Acute sildenafil administration decreases the susceptibility to induced atrial fibrillation in sheep. [PDF]

open access: yesJ Mol Cell Cardiol Plus
Sildenafil has been shown to decrease ventricular arrhythmias. We investigated whether sildenafil could similarly decrease atrial fibrillation (AF) burden through direct effects on atrial electrophysiology.
Madders GWP   +8 more
europepmc   +2 more sources

Preparation and physicochemical characterization of sildenafil cocrystals

open access: yesJournal of Advanced Pharmaceutical Technology & Research, 2021
Sildenafil is a specific inhibitor of the phosphodiesterase type 5 (PDE-5) enzyme that protects cyclic guanosine monophosphate from breakdown by PDE-5. It is a biopharmaceutical categorization system Class II medication with low bioavailability because ...
Somchai Sawatdee   +6 more
doaj   +1 more source

Oral Bioavailability and Pharmacokinetics of Sildenafil Orally Disintegrating Tablets under Various Gastric pH Levels Following Administration of Omeprazole in Rats

open access: yesLife, 2023
Sildenafil citrate, an oral drug used to treat erectile dysfunction, has low water solubility and oral bioavailability. The solubility is greatly influenced by the pH, changing from 37.25 mg/mL to 0.22 mg/mL with a change in pH from 1.2 to 8.0.
Chin-Yu Shih   +4 more
doaj   +1 more source

Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension

open access: yesScientific Reports, 2022
Sildenafil is widely used off-label in pediatric patients with pulmonary arterial hypertension (PAH). This study was conducted to characterize the pharmacokinetics (PK) of sildenafil in term and preterm neonates with PAH, by developing a population PK ...
Su-jin Rhee   +6 more
doaj   +1 more source

Identification, synthesis, and characterization of potential genotoxic impurities of sildenafil citrate drug substance

open access: yesFuture Journal of Pharmaceutical Sciences, 2020
Background Sildenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specifil phophodiesterase type 5 (PDE5). Sildenafil enhances the effect of nitric oxide by inhibiting phosphodiesterase type 5, which is responsible for the ...
P. Rajesh Reddy   +5 more
doaj   +1 more source

Development of a Sildenafil Citrate Microemulsion-Loaded Hydrogel as a Potential System for Drug Delivery to the Penis and Its Cellular Metabolic Mechanism

open access: yesPharmaceutics, 2020
Sildenafil citrate is used to treat mild to moderate erectile dysfunction and premature ejaculation. However, it has low oral bioavailability, numerous adverse effects, and delayed onset of action.
Apichart Atipairin   +5 more
doaj   +1 more source

HPLC-MS/MS Method for Quantitation of Sildenafil and Its Active Metabolite in Human Plasma

open access: yesРегуляторные исследования и экспертиза лекарственных средств, 2020
A high demand for sildenafil-based drugs puts a premium on the development of methods for quantitation of sildenafil in bio-substrates to facilitate pharmacokinetic analysis in bioequivalence studies.
G. G. Rodionov   +5 more
doaj   +1 more source

Portopulmonary hypertension practice patterns after liver transplantation

open access: yesLiver Transplantation, EarlyView., 2022
Abstract Portopulmonary hypertension (POPH) is a type of pulmonary arterial hypertension occurring exclusively in those with portal hypertensive liver disease. Liver transplantation (LT) can significantly improve outcomes. Current guidelines counsel against immediate adjustments to targeted therapy after LT and suggest routine echocardiography as ...
Arun Jose   +3 more
wiley   +1 more source

Oral bioavailability and pharmacokinetics of sildenafil citrate dry foam tablets in rats

open access: yesCogent Medicine, 2018
Sildenafil has low water solubility and oral bioavailability. Dry foam formulations of solid dosage forms of poorly water-soluble drugs may exhibit improved dissolution and bioavailability.
Somchai Sawatdee   +7 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy